as soon as is submitted to ZB.
EpCAM is involved in maintenance of the murine embryonic stem cell phenotype.
Stem Cells 27, 1782-1791 (2009)
Epithelial cell adhesion molecule EpCAM is a transmembrane glycoprotein that is expressed on subsets of normal epithelia, numerous stem- and progenitor-type cells, and most carcinomas and highly overexpressed on cancer-initiating cells. The role of EpCAM in early development, particularly in stem-like cells, has remained unclear. Here, we show that the maintenance of self-renewal in murine embryonic stem (ES) cells depends on the high-level expression of EpCAM. Cultivation of ES cells under differentiation conditions in the absence of leukemia inhibitory factor (LIF) caused down-regulation of EpCAM along with decreased expression of cellular myelocytomatosis oncogene (c-Myc), Sex-determining region Y-Box 2, Octamer 3/4 (Oct3/4), and Stat3. As a consequence ES cells were morphologically differentiated and ceased to proliferate. RNA interference-mediated inhibition of EpCAM expression under self-renewal conditions resulted in quantitatively decreased proliferation, decreased Oct3/4, SSEA-1, and c-Myc expression, and diminished alkaline phosphatase activity. Conversely, exogenous expression of EpCAM partially compensated for the requirement of ES cells for LIF to retain a stem cell phenotype. Thus, murine EpCAM is a transmembrane protein, which is essential but by itself is not sufficient for maintenance of the ES cell phenotype.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Cell adhesion molecules; Cell surface markers; Embryonic stem cells; Self-renewal; Antigen epcam; ep-cam; Self-renewal; Adhesion molecule; Breast-cancer; Expression; Carcinoma; Tumor; Differentiation; Proliferation
ISSN (print) / ISBN
0737-1454
e-ISSN
1549-4918
Journal
Stem Cells
Quellenangaben
Volume: 27,
Issue: 8,
Pages: 1782-1791
Publisher
Wiley
Publishing Place
Durham
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
CCG Molecular Oncology (AGV-KON)
Institute of Clinical Molecular Biology and Tumor Genetics (K.MOLBI)
Institute of Clinical Molecular Biology and Tumor Genetics (K.MOLBI)